OptiScribe
PrivateLast Round
VC Round
Mar 12, 2020
Total Funding Raised
$4.1M
Company Overview
OptiScribe operates in Healthcare & Life Sciences and is based in Switzerland. Its latest recorded funding round was a VC Round in March 2020.
OptiScribe is a healthcare technology company that provides an AI-powered clinical scribe solution with proprietary models fine-tuned for Swiss German medical transcription.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Document Management, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OptiScribe Comparables
Compare OptiScribe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Intonate GmbH | 92% | |
| 44ai AG | 90% | |
| Saipient AG | 88% |
For institutional investors. Book with your work email.
OptiScribe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 12, 2020 | ||||
| VC Round | Sep 18, 2018 | ||||
| Series B | Jun 15, 2017 | ||||
| Series A | Apr 28, 2016 |
For institutional investors. Book with your work email.
OptiScribe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Par Equity | VC Round, Series B, Series A |
| Archangel Investors | VC Round, Series B, Series A |
| Scottish Investment Bank (Scottish Enterprise) | VC Round, Series B, Series A |
| Maven Capital Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2020
Led by Archangel Investors with participation from Maven Capital Partners.
- Sep 18, 2018
$3.6M round led by Maven Capital Partners and Archangel Investors.
For institutional investors. Book with your work email.
OptiScribe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OptiScribe's valuation, stock price, and market status.
Is OptiScribe a public or private company?
OptiScribe is a private company.
What is the current stock price of OptiScribe?
OptiScribe is a private company, so its shares have no public market price. Caplight tracks OptiScribe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OptiScribe worth (valuation)?
Valuation information for OptiScribe is not publicly available.
Can I buy OptiScribe stock?
OptiScribe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OptiScribe's last funding round?
OptiScribe's most recent funding round was VC Round on March 12, 2020.
Who are the main investors in OptiScribe?
Key investors in OptiScribe include Archangel Investors, Maven Capital Partners.
Will OptiScribe IPO soon?
No public IPO plans have been announced for OptiScribe.
How can I track OptiScribe secondary market activity?
Caplight tracks bids, offers, and trades in OptiScribe's shares on secondary markets.